Celltrion Acquires Eli Lilly Facility for USD 330M in Strategic U.S. Expansion
Key Takeaways Strategic Acquisition: Celltrion USA finalizes USD 330 Million purchase of FDA-approved biopharmaceutical manufacturing facility from Eli Lilly in…
USA Plant Setup News and Updates
Latest Updates on New Manufacturing Plants in USA and Compliance Regulations
Key Takeaways Strategic Acquisition: Celltrion USA finalizes USD 330 Million purchase of FDA-approved biopharmaceutical manufacturing facility from Eli Lilly in…
Key Takeaways Massive Investment Commitment: Gilead Sciences announces comprehensive USD 32 Billion investment program spanning through 2030 to bolster U.S.…
Key Takeaways Major Capital Investment: NVIDIA commits USD 5 Billion equity investment in Intel at USD 23.28 per share to…
Key Takeaways Major Investment: Eli Lilly announces a landmark USD 5 Billion manufacturing facility in Goochland County, Virginia, marking the…
Key Takeaways- Record Investment: GSK commits $30 Billion over five years to expand US research, development, and manufacturing infrastructure New…
Key Takeaways Cambrex, a leading U.S. CDMO, valued at USD 4 Billion, nearly double its 2019 acquisition price. U.S. pharmaceutical…
Key Takeaways: Biocon inaugurates its first US-FDA-approved formulations plant in Cranbury, New Jersey. Facility operated by Biocon Generics Inc., having…
Key Takeaways: • USA BioEnergy partners with Johnson Matthey and Honeywell for a sustainable aviation fuel (SAF) production facility in…
Key Takeaways • $150 million investment to expand U.S. manufacturing and research facilities. • Reedsville, PA facility to grow by…
Key Takeaways: • BD is investing $35 million in expanding its prefilled flush syringe manufacturing capabilities in Columbus, Nebraska. •…